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ARTICLE
Gut stem cell aging is driven by mTORC1 via a p38
MAPK-p53 pathway
Dan He1,10, Hongguang Wu1,10, Jinnan Xiang1, Xinsen Ruan1, Peike Peng2, Yuanyuan Ruan2, Ye-Guang Chen3,
Yibin Wang 4, Qiang Yu5, Hongbing Zhang6, Samy L. Habib7, Ronald A. De Pinho8, Huijuan Liu1* & Baojie Li1,9*
Nutrients are absorbed solely by the intestinal villi. Aging of this organ causes malabsorption
and associated illnesses, yet its aging mechanisms remain unclear. Here, we show that aging-
caused intestinal villus structural and functional decline is regulated by mTORC1, a sensor of
nutrients and growth factors, which is highly activated in intestinal stem and progenitor cells
in geriatric mice. These aging phenotypes are recapitulated in intestinal stem cell-specific
Tsc1 knockout mice. Mechanistically, mTORC1 activation increases protein synthesis of
MKK6 and augments activation of the p38 MAPK-p53 pathway, leading to decreases in the
number and activity of intestinal stem cells as well as villus size and density. Targeting p38
MAPK or p53 prevents or rescues ISC and villus aging and nutrient absorption defects. These
findings reveal that mTORC1 drives aging by augmenting a prominent stress response
pathway in gut stem cells and identify p38 MAPK as an anti-aging target downstream of
mTORC1.
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The incidence of aging-related disorders is increasing due toaging of the population1. Nutrient malabsorption is com-mon among the elderly, and often causes anemia and other
illnesses2. Nutrients are absorbed by the intestinal villi, which
are composed of a layer of intestinal epithelial cells (IECs) and the
lamina propria, and the absorption activity is affected by the size
and density of villi3. The epithelial layer is renewed every
4–5 days by Lgr5+ intestinal stem cells (ISCs) following a sym-
metric division and neutral shift pattern4–6, which generate
transient amplifying (TA) progenitor cells that later differentiate
into absorptive or secretory cells7. The densities of crypts and villi
are controlled by ISC fission8. In addition, Bmi1+ quiescent stem
cells, TA cells, and secretory progenitors can revert to Lgr5+ ISCs
after damage to regenerate the villi9–13. It has been reported that
the number of ISCs and ISC regenerative activities are decreased
in 17–24-month-old mice14,15, yet whether aging affects villus
function and how villus aging is controlled remain less well
understood.
mTOR, a sensor of nutrients and growth factors, is a central
regulator of aging and a target for lifespan and healthspan
extension16–20. mTOR forms mTORC1 and mTORC2 complexes,
and mTORC1 activation promotes cell proliferation by increasing
global protein synthesis and other anabolic processes21–24, which
is assumed to cause irreversible cell senescence and/or oxidative
and proteostatic stress and thus aging25–28. However, this
hypothesis is not consistent with the reversible aging theory29,30.
mTORC1 signaling has been shown to be required for IEC pro-
liferation during homeostasis and regeneration31–34, including
regeneration mediated by quiescent ISCs35,36. In addition, several
studies have shown that diet restriction promotes Lgr5+ ISC
expansion via mTORC1 signaling, although conflicting results
have been reported regarding the exact roles played by
mTORC114,37,38. Nonetheless, the mechanisms by which
mTORC1 signaling regulates ISCs and villus aging warrant fur-
ther investigation.
The current genetic study reveals that mTORC1, which is
hyperactivated in IECs, especially ISCs and TA cells of aged mice,
drives villus aging by inhibiting ISC/progenitor cell proliferation
through amplifying the MKK6-p38-p53 stress response pathway,
with MKK6 protein synthesis being upregulated by mTORC1
activation. Villus aging can be slowed or prevented by targeting
p38 MAPK or p53. These genetic results establish a prominent
stress response pathway as an mTORC1 downstream effector in
aging control, elucidate the mechanisms governing villus aging,
and identify p38 MAPK as an antiaging target downstream of
mTORC1 signaling.
Results
Aging causes a decrease in the numbers of crypts and TA cells.
To understand aging of the nutrient-absorbing organ, we col-
lected small intestines from normal B6 mice of various ages,
which were bred and housed in the same facility. Histological
analysis revealed that 16 or 17.5-month-old mice, compared with
2-, 3.5-, 8-, and 12-month-old mice, showed significant decreases
in the height and number of villi in the proximal and distal
jejunum (Fig. 1a; Supplementary Fig. 1a, b). The 17.5-month-old
mice showed a 12% increase in body weight compared with 2–3-
month-old mice. Mice at 24 months of age also showed villus
structural deterioration (Supplementary Fig. 1c). These results
indicate a decline in the absorption surface in aged mice, which
are disagreeable with a recent study by Nalaparenddy et al.
reporting an increase in the villus size in old mice15. While the
causes of this discrepancy can be complex, one explanation
could be that Nalaparenddy’s study used young and old
mouse cohorts purchased from different suppliers15. We found
that 16- or 17.5-month-old mice showed decreases in nutrient-
absorbing activities for unmetabolizable L-glucose, amino acids,
and fatty acids (Fig. 1b; Supplementary Fig. 1d).
The old mice also showed increased sensitivity to ionizing
radiation (IR), manifested by greater decreases in the numbers of
crypts and proliferating cells and greater increase in apoptotic
cells than young mice at day 2 post IR (Fig. 1c; Supplementary
Fig. 2a). This was associated with a decrease in PCNA and cyclin
E and an increase in p53 in crypt samples (Supplementary
Fig. 2b). Similar results were obtained at day 3 post IR
(Supplementary Fig. 2c). The increased damage in old mice
may be the cause of compromised villus regeneration observed at
day 6 post IR, manifested by decreases in the height and number
of villi and crypts (Fig. 1d; Supplementary Fig. 2d). Overall, these
findings indicate that aging is associated with a deterioration of
villus structure and function, increased sensitivity to stress, and
compromised regeneration.
Old mice also showed decreases in the height and number of
crypts, the ISC/progenitor-containing glands that control villus size
and density. We observed a decrease in the number of Ki67+
progenitor cells (Fig. 1a, e; Supplementary Fig. 1a), but no
significant changes in the numbers of apoptotic or senescent cells
or differentiation of villus cells after normalized to the villus size
(Supplementary Fig. 2e–g). Although the numbers of villi and
crypts were decreased in old mice, the crypt-to-villus ratio was
unaltered (Supplementary Fig. 2h), suggesting that aging-related
decreases in villus height and density may be caused by decreases in
the numbers of proliferating TA cells and crypts, respectively.
Yilmaz’ group also reported that aging caused decreases in the
number and regeneration ability of ISCs, but not defect in goblet or
enterocyte differentiation14. Taken together, our and others’ studies
suggest that villus aging-associated decrease in villus size and
density are likely caused by defects in ISCs and TA progenitors14,15.
Hyperactivated mTOR in IECs contributes to villus aging.
mTOR activation is implicated in the aging process34,39. Immu-
nostaining showed that p-4E-BP1 and p-S6, indicators of
mTORC1 activation, were increased with age in IECs, especially
in crypt cells (Fig. 1f). Western blot analysis confirmed an
increase in mTORC1 activation in crypt samples of old mice
(Fig. 1g). Because the number of ISCs was too limited for western
blot analysis, we sorted Lgr5+ ISCs from 3.5- and 17.5-month-old
Lgr5-GFP-CreERT mice and immunostained them for p-S6. We
found that substantially more ISCs displayed mTORC1 activation
in old mice (Fig. 1h). The factors that cause mTORC1 hyper-
activation in aged IECs and ISCs may include systemic and niche
cues and, warrant further investigation39,40.
Interestingly, treatment of 16-month-old mice with rapamycin
(RAP), an mTORC1 inhibitor21, for 1.5 months inhibited
mTORC1 activity (Supplementary Fig. 2i) and partially rescued
aging-like phenotypes, including decreases in villus height
and density and nutrient absorption activities, increased sensi-
tivity to IR at day 2, and compromised villus regeneration at day 6
post IR (Fig. 1a–d; Supplementary Fig. 2a–d). It has been
previously reported that acute RAP inhibited villus regeneration
in normal mice31,33,36. Here, we carried out the above experi-
ments 3 days after completion of drug treatment to avoid possible
acute effects of RAP. Moreover, RAP mainly rescued IR-induced
decrease in cell proliferation and increase in apoptosis at day 2 or
3 post IR (Fig. 1c; Supplementary Fig. 2a–c), which might help
villus regeneration. In addition, RAP partially rescued the
decreases in the height and number of crypts and the number
of proliferating TA cells in old mice (Fig. 1a, e). These results
suggest that enhanced mTORC1 activation contributes to villus
natural aging.
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Tsc1 ablation in IECs causes villus premature aging. To test
whether mTORC1 activation causes villus aging, we ablated Tsc1,
a disease gene encoding an mTOR suppressor, using Villin-Cre
mice. Villin is expressed in all small intestinal IECs, including
ISCs, but not colon crypts41. Villin-Cre;Tsc1f/f mice exhibited
enhanced mTOR activation in the whole villi (Supplementary
Fig. 3a). We found that 2- or 3-month-old Villin-Cre;Tsc1f/f mice
showed increases in the number and size of crypts, but insignif-
icant increases in villus size (Supplementary Fig. 3b). The nutrient
absorption rates were not altered in these mice (Supplementary
Fig. 3c), suggesting that mTORC1 activation in IECs per se does
not affect nutrient absorption in the presence of normal villi.
Surprisingly, 4–6-month-old mutant mice showed villus/crypts
similar to age-matched wild-type mice (Supplementary Fig. 3b).
Starting from 7 months of age, the mutant mice displayed
aging-related changes, including decreases in villus height and
density, nutrient absorption activities, and villus regeneration
(Supplementary Fig. 3b–d). The compromised regeneration in
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Villin-Cre;Tsc1f/f mice was likely caused by increases in IR-
induced cell death and villus damage at day 2 post IR
(Supplementary Fig. 3d). Overall, these results indicate that
Tsc1 deletion in IECs cause villus premature aging.
Tsc1 ablation in ISCs-induced villus aging is rescued by RAP.
The above studies show that nutrient absorption defects observed
in villus natural or premature aging models are associated with
decreases in villus size and density, whereas mTORC1 activation
per se in IECs does not affect nutrient absorption activities at
young age (Supplementary Fig. 3c). Since villus size and density
are controlled by ISC and progenitor cells, we ablated Tsc1 in
ISCs using Lgr5-CreERT mice4. Lgr5-CreERT reportedly only
labels part of ISCs after tamoxifen (TAM) administration and
generates chimeric labeling patterns4. Our lineage-tracing studies
revealed that three doses of TAM administered daily to 1-month-
old Lgr5-CreERT;tdTomato mice labeled 65% of the crypts by
2 months of age (Supplementary Fig. 4a). A majority of the cells
in almost all the villi were Tomato-labeled, likely because each
villus contains at least six crypts7.
We found that TAM-induced Tsc1 ablation in Lgr5-CreERT;
Tsc1f/f mice at 1 month of age led to an increase in mTORC1
activation in most of the cells of almost all the villi by 2 months of
age (Fig. 2a; Supplementary Fig. 4b). These mice showed
increases in the size and number of crypts, but insignificant
increases in villus size (Fig. 2b). The nutrient absorption activities
were unaltered in these mutant mice (Fig. 2c), confirming that
mTORC1 activation in IECs per se does not affect their nutrient
absorption activities. However, mice of 7 months of age or older
displayed a slight but insignificant decrease in body weight and
premature aging phenotypes, including changes in villus height
and density (proximal and distal jejunum) and nutrient
absorption activities (Fig. 2b, c; Supplementary Fig. 5a).
The mutant mice also showed increased sensitivity to IR,
manifested by greater decreases in the numbers of crypts and
proliferating cells and greater increase in apoptotic cells than
control mice at day 2 post IR (Fig. 2d; Supplementary Fig. 5b),
associated with a decrease in PCNA and cyclin E and an increase
in p53 in crypt samples (Supplementary Fig. 5c). Similar results
were obtained at day 3 post IR (Supplementary Fig 5d). This
might have led to compromised villus regeneration at day 6 post
IR (Fig. 2e). Although mTOR signaling is required for villus
regeneration31,33,36, we found that mTOR hyperactivation
sensitized the cells to IR-induced damage, which might delay
the regeneration process. Note that most of the crypts and almost
all the villi showed increased mTORC1 activation in 8-month-old
Lgr5-CreERT; Tsc1f/f mice to a greater extent than that in 2-
month-old Lgr5-CreERT; Tsc1f/f mice (Supplementary Fig. 4b).
The villus premature aging phenotypes of Lgr5-CreERT; Tsc1f/f
mice could be partially rescued by 1.5 months of RAP treatment
starting at 6.5 months of age (Fig. 2a–e). This included the rescue
of IR-induced decrease in cell proliferation and increase in
apoptosis at day 2 or 3 post IR (Fig. 2d; Supplementary Fig. 5d).
RAP could also inhibit mTORC1-driven crypt overgrowth in
Lgr5-CreERT;Tsc1f/f mice at 2 months of age (Supplementary
Fig. 5e), suggesting that villus growth and aging are at least
partially mediated by elevated mTORC1 activation. In addition,
Tsc1 deletion led to an overgrowth phenotype in colon crypts at
2 months of age, followed by crypt atrophy at 7 months of age,
which were rescued by RAP (Supplementary Fig. 5b). These
results revealed biphasic effects of mTORC1 activation on Lgr5+
ISCs in the small intestine and colon.
Our findings that (i) mTORC1 is greatly activated in ISC and
progenitor cells of aged mice; (ii) nutrient absorption is normal
even when mTORC1 is activated in IECs of young Lgr5-CreERT;
Tsc1f/f mice and Villin-Cre;Tsc1f/f mice, which have normal villus
size and density; (iii) aging-related nutrient absorption decline is
always associated with decreases in villus size and density, which
are controlled by Lgr5+ ISCs, suggesting that activated mTORC1
promotes villus aging mainly through ISCs.
mTORC1-driven villus aging may not rely on overgrowth. Both
Villin-Cre;Tsc1f/f mice and Lgr5-CreERT;Tsc1f/f mice showed
increases in the size of crypts at 2–3 months of age before
showing villus premature aging at 7–8 months of age (Fig. 2b;
Supplementary Fig. 3b). Is it possible that villus overgrowth at
2–3 months of age causes villus premature aging later? Our
observation that RAP administration to 6.5-month-old mice
could rescue villus aging phenotypes, suggests that villus pre-
mature aging is not an inevitable consequence of mTORC1-
driven crypt overgrowth at 2–3 months of age (Fig. 2b–e); such
rescue may not occur if mTORC1-driven aging is caused by
irreversible ISC/TA cell replicative senescence and/or apoptosis.
For validation, we induced Tsc1 ablation in Lgr5-CreERT;Tsc1f/f
mice at 6.5 months of age. These mice displayed aging-like
phenotypes at 8 months of age, including changes in villus height
and density and nutrient absorption activities (Supplementary
Fig. 6a–c). However, TAM administration failed to induce crypt
overgrowth at 7.5 months of age (Supplementary Fig. 6d).
Overall, these results suggest that mTORC1-driven villus pre-
mature aging may not rely on mTORC1-driven crypt overgrowth.
mTORC1 activation eventually suppresses ISC proliferation.
What caused the decreases in villus height and density in 8-
month-old Lgr5-CreERT;Tsc1f/f mice? We found that the decrease
in villus height was accompanied by decreases in the number of
IECs and the number of Ki67+ progenitors (Figs. 2b, 3a, b). On
the other hand, IEC apoptosis, senescence, or differentiation were
not significantly altered (Supplementary Fig. 5f–h). In addition,
Fig. 1 Enhanced mTORC1 activation in ISCs/TA cells of geriatric mice drives villus natural aging. a–d Seventeen and half-month-old mice showed
deterioration in villus and crypt structures (right panels: quantitation data) (a), decreased nutrient absorption activities (b), increased sensitivity to IR-
induced decreases in the numbers of crypts and proliferating cells at day 2 post IR (c), and compromised regeneration (decreases in the height and number
of villi and crypts) at day 6 (d) compared with young mice, which were partially rescued by 1.5 months of RAP treatment (3 mg/kg body weight) starting at
16 months of age. Data are expressed as mean ± SEM. N= 5 mice per group. *P < 0.05, **P < 0.01 (determined using Student’s t test). e Seventeen and
half-month-old mice showed decreases in the height and number of crypts and the number of proliferating TA cells (based on (a)), which were rescued by
RAP. Data are expressed as mean ± SEM. N= 5 mice per group. *P < 0.05, **P < 0.01 (determined using Student’s t test). f Representative images
(proximal jejunum midline sections) showed that mTORC1 activation was increased with age in crypt cells. g Western blot results showed that mTORC1
activation was increased in the crypt samples of 17.5-month-old mice compared with 3.5-month-old mice. Isolated crypts were directly lysed and used for
WB analysis. Data are expressed as mean ± SEM. N= 3 mice per group. *P < 0.05, **P < 0.01 (determined using Student’s t test). h More Lgr5+ ISCs
isolated from 17.5-month-old mice showed mTORC1 activation than those from 3.5-month-old mice, which was suppressed by RAP treatment. Lgr5+ ISCs
were isolated from the small intestines of Lgr5-GFP-CreERT mice with FACS sorting and stained for p-S6. Right panel: quantification data (mean ± SEM).
N= 6 mice per group. **P < 0.01 (determined using Student’s t test).
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the decrease in the number of villi was accompanied by a decrease
in the number of crypts (Fig. 2b). Since the villus-to-crypt ratio
was not altered (Fig. 3c), we conclude that decreased villus density
is caused by decreased numbers of crypts. Overall, these results
suggest that the decreases in villus size and density in Lgr5-
CreERT;Tsc1f/f mice at 7–8 months of age are caused by defects in
the crypts and TA cell proliferation.
We then used ex vivo organoid cultures to verify these findings.
We isolated crypts from 2-month-old normal or Villin-Cre; Tsc1f/
f mice and performed ex vivo minigut organoid cultures.
Tsc1-deficient crypts showed increased growth in organoid
cultures; however, they lost the ability to propagate at passage 3
(Fig. 3d), confirming the biphasic roles of mTORC1 signaling in
crypt growth and aging.
Tsc1 ablation-induced premature villus aging was also
associated with defects in ISCs. At 8 months of age, the number
of crypts containing Lgr5-expressing ISCs and the number of
Lgr5+ ISCs per crypt were decreased, whereas the opposite results
were observed at 2-month-old Lgr5-CreERT;Tsc1f/f mice (Fig. 3e).
Moreover, the number of proliferating Lgr5+ ISCs was also
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decreased in 8-month-old Lgr5-CreERT;Tsc1f/f mice (Fig. 3e).
Similarly, the numbers of Lgr5+ ISCs and proliferating Lgr5+
ISCs were decreased in naturally aged mice (Fig. 3f). Overall,
these results suggest that both Tsc1 deficiency-induced villus
premature aging and natural aging are likely caused by decreases
in the number of ISC/TA cells.
mTORC1 increases MKK6 protein synthesis and p38 activa-
tion. To understand the molecular basis underlying mTORC1-
driven villus premature aging and decreased ISC/TA cell pro-
liferation, we used antibody arrays (204 antibodies) to compare
the expression and activation of proteins involved in cell pro-
liferation. To this end, we compared snap-frozen intestine
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samples of Villin-Cre;Tsc1f/f and control mice to minimize pos-
sible effects of crypt isolation procedures on protein phosphor-
ylation. We found that Tsc1 deficiency altered the expression and
activation of several signaling molecules, including p38 MAPK,
MEK1, and p53 (Supplementary Table 1). We chose p38 MAPKs
for further studies since they are stress-responsive kinases that are
involved in aging42. Western blot analysis revealed that the levels
of MKK6 protein and p38 MAPK activation were increased in
Tsc1−/− villus samples and Tsc1−/− organoid samples (Fig. 4a, b).
Mechanistically, Tsc1 deficiency did not significantly affect the
mRNA levels of Mkk6 in crypt samples (Fig. 4c). Instead,
incorporation of radio-labeled methionine into MKK6 was
increased in Tsc1−/− primary enteroblasts, which were sup-
pressed by RAP treatment (Fig. 4d). Increases in MKK6 protein
and p38 MAPK activation were also observed in Tsc1−/− MEFs
(Supplementary Fig. 7a–c). We found that transient knockdown
of MKK6 with siRNA led to a decrease in p38 MAPK activation
(Supplementary Fig. 7d), indicating that elevated MKK6 is
responsible for enhanced p38 MAPK activation in Tsc1-deficient
cells. mTORC1 has been shown to increase protein synthesis of
transcripts with 5′ terminal oligopyrimidine (TOP) or TOP-like
motifs43. Mouse Mkk6 transcripts contain several TOP or TOP-
like tracts in the 5′ untranslated region (Supplementary Fig. 7e).
These results suggest that mTORC1 activation promotes protein
synthesis of MKK6 and thus enhances p38 MAPK activation.
Moreover, comparison of crypt samples of 2- and 8-month-old
Lgr5-CreERT;Tsc1f/f mice by western blot revealed that p38
MAPK activation was further augmented in the old mice,
accompanied by an increase in mTORC1 activation (Fig. 4e).
Immunostaining results confirmed enhanced p38 activation in
the crypts of old mice (Supplementary Fig. 7f). Increased
mTORC1 activation was also observed on intestine sections of
8-month-old mice compared with 2-month-old mice (Fig. 1f;
Supplementary Fig. 4b). These results suggest that extrinsic and/
or intrinsic changes at 7–8 months of age may be involved in
enhanced activation of mTORC1 and p38 MAPKs in ISCs
and IECs.
Mapk14 ablation prevents mTORC1-driven villus and ISC
aging. Because the p38 MAPK pathway plays a negative role in
cell proliferation under most conditions42, enhanced p38 MAPK
activation may underlie mTORC1-driven ISC/progenitor aging.
To test this possibility, we ablated Mapk14, which encodes p38α,
in Villin-Cre;Tsc1f/f mice to circumvent the possible complica-
tion of chimeric ablation of Tsc1 and Mapk14. We found that 2-
month-old Villin-Cre;Mapk14f/f mice, like Villin-Cre;Tsc1f/f
mice, showed decreased p38α expression and increases in the
number and size of crypts (Supplementary Fig. 8a, b), as pre-
viously reported44. Moreover, Mapk14 ablation prevented the
development of aging-related histological phenotypes, leading to
crypt overgrowth and fusion in 8-month-old Villin-Cre;Tsc1f/f
mice (Supplementary Fig. 8b).
We also ablated Mapk14 in Lgr5-CreERT;Tsc1f/f mice (Supple-
mentary Fig. 9a), and found that deletion of just one allele of
Mapk14 prevented the development of villus premature aging
phenotypes at 8 months of age, including defects in villus
structure, nutrient absorption activities, and villus regeneration at
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day 6 post IR (Fig. 5a–c). Mapk14 haploinsufficiency also rescued
increased sensitivity to IR at day 2 post IR (Supplementary
Fig. 9b–d), the decrease in the numbers of proliferating TA cells,
Lgr5+ ISC-containing crypts, Lgr5+ ISCs per crypt, and
proliferating Lgr5+ ISCs, as well as mTORC1-driven colon crypt
atrophy (Fig. 5d; Supplementary Fig. 9e). Overall, these genetic
data suggest that p38 MAPKs mediate mTORC1-driven ISC and
villus premature aging. A recent study reported that
mitochondria-produced reactive oxygen species activate p38
MAPKs to drive crypt formation in organoid cultures45.
Together, these results suggest that p38 MAPKs play critical
roles in ISC activities.
A p38 MAPK inhibitor partially rescues villus natural aging.
The above studies show that p38 MAPKs play an important role
in mTORC1-driven villus/ISC premature aging. To test whether
p38 MAPK plays a role in villus natural aging, we compared the
crypts of 3.5- and 17.5-month-old normal mice and discovered
increases in MKK6 expression and p38 activation in the old mice,
which were associated with increased mTORC1 activation and
were suppressed by RAP treatment (Fig. 6a). We then tested
whether a small molecule inhibitor of p38 MAPK can slow villus
natural aging. Administration of SB203580 to 16-month-old
normal mice for 1.5 months inhibited p38 MAPK activation,
manifested by decreases in phosphorylation of p38 MAPK sub-
strate Creb (Supplementary Fig. 9f), and alleviated villus aging
phenotypes, including villus structure, nutrient absorption
activity, and compromised regeneration (Fig. 6b–d), as well as
decreases in the number of proliferating TA cells (Fig. 6b).
Inhibition of p38 MAPK has been shown to slow aging of skeletal
muscle46. Moreover, we found that organoids derived from 17.5-
month-old mice showed defects in growth and crypt formation,
which were partially rescued by addition of low doses of
SB203580 or RAP to the cultures (Fig. 6e), suggesting that the
effects of SB203580 and RAP are directly on crypt cells. Fur-
thermore, Lgr5-CreERT;Mapk14+/f mice (TAM injected at
2 months of age) showed modest villus/crypt overgrowth but not
aging-like phenotypes at 16 months of age (Fig. 6f). These results
suggest that elevated p38 signaling inhibits TA cell proliferation
and promotes villus natural aging.
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mTORC1 upregulates p53 and p16 expression via p38 MAPKs.
How does p38 MAPK activation, downstream of mTORC1-
MKK6, induce villus aging? Accumulating evidence suggests that
p38 MAPK regulates aging via p53, p16, and other molecules47–49.
Our antibody array and western blot results revealed that naturally
aged crypt samples or Tsc1-deficient prematurely aged crypt
samples showed increased levels of p53 and p16, which were
suppressed by RAP treatment of the mice (Supplementary
Fig. 10a, Supplementary Table 1). Moreover, aging- or mTORC1
activation-induced increases in the levels of p53 and p16 in crypt
samples were suppressed by Mapk14 deficiency or inhibition
(Supplementary Fig. 10b, c). These results indicate that mTORC1
activation induces p53 and p16 expression in a p38 MAPK-
dependent manner.
p53 is critical in mTORC1-p38 MAPK-controlled villus aging.
We then tested whether p53 and p16 contribute to mTORC1-
driven villus aging. Although Trp53−/− mice started to develop
tumors at 5–6 months of age, many survived up to 7–8 months
with no obvious tumor development. While 2- or 8-month-old
Trp53−/− mice showed normal villus structure, Trp53 deficiency
enhanced crypt growth in Villin-Cre;Tsc1f/f mice and largely
prevented development of villus premature aging phenotypes,
including decreases in villus structure, nutrient absorption
activities, increased sensitivity to IR, and decreased villus regen-
eration at 7 months of age (Fig. 7a–c; Supplementary
Fig. 10d). We also repeated these experiments using Lgr5-
CreERT;Tsc1f/f;Trp53−/− mice and found that Trp53 deficiency
rescued the decreases in proliferating TA cells and the numbers of
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elevated MKK6 expression, increased p38 MAPK activation, and increased p53 and p16 levels, which were suppressed by RAP treatment for 1.5 months
starting at 16 months of age. Right panel: quantification data (mean ± SEM). N= 3 mice per group. *P < 0.05, **P < 0.01 (determined using Student’s t test).
b–d Inhibition of p38 MAPK largely rescued the deterioration in villus and crypt structures (b), decreased nutrient absorption activities (c), and
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Lgr5+ ISC-containing crypts, Lgr5+ ISCs per crypt, and pro-
liferating Lgr5+ ISCs as well (Fig. 7d). These results indicate that
p53 plays an important role in Tsc1 deletion-driven villus aging.
p16 (encoded by Cdkn2a) plays an important role in aging of
several tissues48,50. However, 2- or 8-month-old Cdkn2a−/− mice
showed normal villus histology, and Cdkn2a ablation failed to
affect villus growth in 2-month-old Villin-Cre;Tsc1f/f mice.
Cdkn2a deficiency showed negligible effects on aging-related
histology in 8-month-old Villin-Cre;Tsc1f/f mice (Supplementary
Fig. 10e). These results suggest that p16 plays a lesser role than
p53 in mTORC1-driven villus aging.
Discussion
Aging-related nutrient malabsorption is a common disorder, yet
the underlying etiology remains elusive. This study reveals that
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Fig. 7 Ablation of Trp53 prevents mTORC1-driven villus aging. a–c Deletion of Trp53 rescued the deterioration in villus and crypt structures (a),
decreased nutrient absorption activities (b), and compromised regeneration (c) in 8-month-old Villin-Cre;Tsc1f/f mice. Data are expressed as mean ± SEM.
N= 5 mice per group. *P < 0.05, **P < 0.0 (determined using Student’s t test). d Trp53 ablation rescued the decrease in the numbers of ISCs and
proliferating ISCs in 8-month-old Lgr5-GFP-CreERT;Tsc1f/f mice. The intestinal sections were immunostained for PCNA, and cells positive for PCNA and GFP
were counted and normalized to the total numbers of Lgr5+ ISCs. Bottom panels: quantification data (mean ± SEM). N= 5 mice per group. *P < 0.05,
**P < 0.0 (determined using Student’s t test). e A model for controlling gut stem and progenitor cell aging by mTORC1.
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aging is associated with decreases in villus height and density and
nutrient absorption activities, as well as increased sensitivity to
IR, which may be the cause of compromised villus regeneration.
These aging-related phenotypes are recapitulated in 7–8-month-
old Lgr5-CreERT;Tsc1f/f mice and Villin-Cre;Tsc1f/f mice. Aging-
related villus structural deterioration was accompanied by
decreases in the number and height of crypts and the number and
proliferation of ISCs. These findings, together with our observa-
tion that Tsc1 ablation and mTORC1 activation in IECs do not
affect villus cell differentiation or nutrient absorption activities in
2–3-month-old mice, suggesting that aging-related malabsorption
is mainly attributable to exhaustion of gut stem cells and their
reduced activity, which result in decreases in villus size and
density.
While aging can be caused by complex mechanisms, we pro-
vide genetic evidence that villus and ISC aging may involve
mTORC1 signaling. mTORC1 is strongly activated in ISCs and
TA cells in old mice, and inhibition of mTORC1 with RAP for
only 1.5 months partially restored the structure and function of
intestinal villi in old mice. Moreover, Tsc1 ablation in Lgr5+ ISCs
leads to villus premature aging phenotypes and crypt atrophy in
Paneth-less colon, which were rescued by RAP treatment. These
data suggest that mTORC1 is an important regulator of gut stem
cell and villus aging. Our conclusions are generally consistent
with those of a recent study showing that diet restriction helps
expand ISCs by inhibiting mTORC1 signaling37, but inconsistent
with another study showing that diet-restriction-induced ISC
expansion is inhibited by RAP38. What causes enhanced
mTORC1 activation in aged IECs and ISCs? It is possible that
age-related changes in systemic factors may be involved, which
are now being vigorously explored40,51,52. These factors may
include nutrients, metabolites, and growth factors14,45, and war-
rant further investigation.
Our studies also show that mTORC1 activation promotes ISC/
TA cell proliferation in young mice. While mTORC1-driven cell
hyperproliferation and anabolism are generally presumed to
cause aging53, our study suggests that in the fast-turnover
intestinal villi, mTORC1 activation-induced aging may not
necessarily require mTORC1-induced overgrowth in earlier
stages based on the following observations: (i) ablation of Tsc1 in
Lgr5+ ISCs at 6.5 months of age circumvents the villus over-
growth phase, which occurs at 2–3 months of age, but still
induces villus premature aging; (ii) villus aging in Tsc1-deficient
mice can be partially rescued by the administration of p38 or
mTORC1 inhibitors to old mice; and (iii) Mapk14 ablation
increases crypt cell proliferation, but rescues villus premature
aging. These results suggest that Tsc1 deletion-driven ISCs
exhaustion and villus aging are not directly caused by mTORC1-
driven cell overproliferation.
Instead, we show that mTORC1 signaling promotes villus
aging by augmenting a cell stress response pathway. mTORC1
activation increases MKK6 expression, potentiates p38 MAPK
activation, and enhances p53 expression, leading to ISC exhaus-
tion and decreases in villus size and density (Fig. 7f). Moreover,
mTORC1 activation also increases cell sensitivity to IR and
compromises villus regeneration in a p38 MAPK-p53-dependent
manner, which is consistent with cell-based studies showing that
mTORC1-activated cells are more sensitive to stress47. The nat-
ural function of the mTOR-MKK6-p38 MAPKs-p53 pathway
may be to balance mTORC1-induced overgrowth and protect
cells from runaway proliferation and oncogenic transformation,
which is consistent with the concept that aging acts as an anti-
hyperplasia mechanism42.
This study places p38 MAPK downstream of
mTORC1 signaling in controlling ISC/villus aging. p38 MAPK
has been implicated in the aging of skeletal muscle and other
tissues42. We show that a p38 MAPK inhibitor can effectively
improve the structure and function of naturally aged villi and that
Mapk14 ablation can prevent ISC and villus aging. These results
justify p38 MAPK as an antiaging target. Since p38 MAPKs can
be activated by various stress and cytokines, p38 MAPK may act
as a nexus to incorporate environmental cues to influence the
aging process. These insults may include mTOR activation-
induced oxidative and ER/proteostatic stress, which may lead to
further activation of p38 MAPKs (Fig. 7f). Our findings favor a
model in which mTORC1 signaling cooperates with p38 MAPK-
activating stresses to regulate aging of tissue stem cells (Fig. 7f).
Emerging evidence indicates that mTOR is a central regulator
of aging that may mediate RAP- and diet restriction-induced
extension of the lifespan and healthspan. While mTORC1-driven
cell proliferation and incurred oxidative and proteostatic stress
are generally believed to underlie cell and tissue aging, this study
provides genetic evidence that mTORC1 can regulate tissue stem/
progenitor cell aging and tissue aging via a prominent stress
response pathway. These findings reveal a mechanism by which
mTORC1 signaling regulates aging and this working model can
explain the reversibility of aging.
Methods
Mice maintenance. Tsc1f/f, Villin-Cre, and Trp53−/− mouse lines were purchased
from The Jackson Laboratories. The Lgr5-CreERT mouse was generated in Hans
Clevers’ lab. Mapk14f/f was generated in Yibin Wang’s lab. Cdkn2a−/− mouse was
generated in Ron Depinho’s lab. These mice were maintained in SPF mouse facility
of Shanghai Jiao Tong University. Most of the mice were originally in a 129/B6
background and were crossed back to B6 for four times. They can live up to
30 months in the facility. Animal experiments were carried out in accordance with
recommendations in the National Research Council Guide for Care and Use of
Laboratory Animals and in comply with relevant ethical regulations for animal
testing and research, with the protocols approved by the Institutional Animal Care
and Use Committee of Shanghai Jiao Tong University.
Mouse drug administration and radiation. Tamoxifen (Sigma) was dissolved in
corn oil, and mice were injected with 10 mg per dose daily for 3 consecutive days to
activate CreERT. To inhibit mTORC1, mice were injected with RAP (3 mg/kg,
Selleck, s1039) daily for the periods indicated in the study. To inhibit p38 MAPKs,
mice were injected with SB203580 (5 mg/kg, Selleck, S1076) daily for the time
indicated in the study. For long-term RAP or SB203580 administration, we waited
at least 3 days after completion of drug treatment before doing experiments to
avoid acute effects of the drugs. For ionizing radiation, mice were exposed to γ-
irradiation with a dose of 5 Gy, and mice were killed 2, 3, or 6 days after IR.
Nutrients absorption assays. The mice were fasted for 16 h before nutrient
assays54–56. For glucose absorption test, the mice were gavaged with L-glucose
solution (2 mg/g, body weight) in PBS, blood samples were collected from the tail
vein at 0, 7, 15, 30, 60, 90, and 120 min, and blood glucose levels were determined,
with the value at 60 min used as an indication of glucose absorption activity. For
amino acid absorption test, the mice were gavaged with amino acids mixture
(2 mg/g, body weight), blood samples were collected from the tail vein at different
time points, and blood amino acid levels were determined with HPLC. The peak
value (at 1 h) was used to represent amino acid absorption activity. For fatty acid
absorption test, the mice were gavaged with BODIPY® 500/510 C1, C12 fatty acids
(2 μg/g body weight, Molecular Probes #D3823), or olive oil (10 μl/g body weight).
After 2 h, small intestines were excised and frozen in OCT. Ten-μm sections were
cut, mounted with ProLong® Diamond Antifade Mountant with DAPI, and
examined under the fluorescence microscope. In nutrient absorption studies, no
significant difference was observed between male and female mice.
Histology and immunohistochemistry. Small intestines were harvested immedi-
ately after killing and washed with PBS. The tissues (the proximal and distal
jejunum and proximal colon) were fixed in 4% paraformaldehyde, embedded in
paraffin, sectioned longitudinally at 4-μm, and the midline sections were stained
with hematoxylin and eosin (H/E), ALP or Alcian Blue. For immunostaining,
antigen retrieval was carried out by boiling the sections in citrate buffer, pH 6, for
10 min, followed by cooling for 60 min at room temperature. To eliminate endo-
genous peroxidases, tissues were treated in methanol containing 3% H2O2 for
30 min. Tissues were permeabilized with 0.1% Triton X-100 for 30 min. The sec-
tions were blocked in 10% goat serum for 30 min followed by primary antibodies
incubation at 4 °C overnight, and secondary antibody incubation for 60 min at
37 °C. Antibodies against Ki67 (ab15580, 1:100) and Lysozyme (ab108508, 1:100)
were purchased from Abcam. Antibodies against GFP (2956, 1:200), p-S6 (2211,
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1:100), p-p38 (9211, 1:100), and p-Erk1/2 (9106, 1:200) were purchased from Cell
Signaling Technology. Antibodies against PCNA (sc-56, 1:100) were purchased
from Santa Cruz Biotechnology.
Antibody array analysis. To compare the activation and expression of proteins
involved in cell proliferation, we chose to use snap-frozen small intestine samples
of wild-type and Villin-Cre; Tsc1f/f mice since isolated crypts by enzyme digestion
at 37 °C produced inconsistent results. The samples were analyzed with phospho-
Exploerer (PEX100) by the H-Wayen Biotechnologies.
Crypt isolation and culture and GFP+ ISCs sorting. To isolate crypts, the small
intestine, mostly jejunum and ileum, was removed immediately, and the stool was
flushed out with ice-cold PBS. The tissues were dissected and opened longitudinally
and cut into 1 -cm pieces, which were placed in PBS with 2 mmol/L EDTA for
30 min at 4 °C and then in PBS with 54.9 mmol/L d-sorbitol and 43.4 mmol/L
sucrose. The pieces were then vortexed for 1–2 min, filtered by a 70 μm sterile cell
strainer, and enriched by centrifugation at 150 g for 10 min at 4 °C. Nearly 500
crypts were suspended in 50 μL growth factor reduced phenol-free Matrigel (BD
Biosciences). Afterward, a 50 μL droplet of Matrigel/crypt mix was put in the center
well of a 12-wells plate and after 30 min of polymerization, 650 μl of minigut
medium was overlain. Minigut medium (advanced DMEM/F12 supplemented with
HEPES, l-glutamine, N2, and B27) was added to the culture with R-Spondin,
Noggin, and EGF. The medium was changed every 2–3 days. For GFP+ ISCs
isolation, we first isolated crypts and digested them at 37 °C for 5 min with 0.25%
trypsin, centrifuged at 150–200 g for 3 min, and resupensed in 0.1% BSA in ice-cold
PBS. We purified GFP+ cells with FACS sorting and collected. These cells were
resupensed in PBS, smeared onto coated slides, dried at 4 °C. The slides were then
fixed in 4% PFA, and GFP+ cells were countered under the fluorescence
microscope.
Epithelial cell isolation and culture. For primary IECs isolation, intestines were
opened longitudinally and washed in Ca2+ and Mg2+-free Hanks’ balanced salt
solution (HBSS) containing 2% glucose, 25 ng of amphotericin B/ml, 100 U of
penicillin/ml, and 100 mg of streptomycin/ml, which were cut into 1-mm frag-
ments and incubated for 10 min at 22 °C on a shaker platform in HBSS containing
collagenase XIa (Sigma), 2% bovine serum albumin, and 0.2 mg of soybean trypsin
inhibitor/ml (Sigma). Cells and small sheets of intestinal epithelium were separated
from the denser intestinal fragments by harvesting supernatants after two 60-s
sedimentations in medium containing Dulbecco’s modified Eagle medium
(DMEM) (Gibco), 10% sorbitol (Gibco), 100 U of penicillin/ml, 100 mg of strep-
tomycin/ml, and 5% fetal bovine serum. Cells were centrifuged five times at 1200 g
for 3 min in DMEM plus 2% sorbitol. Supernatants were discarded, and the cells
were cultured in 10-cm plates coated with 40 ml of Matrigel per cm2 diluted 1:2 in
phenol-red-free DMEM (Sigma).
S35-methionine incorporation assay. Primary IECs were pre-incubated with
DMEM without methionine and cysteine for 30 min, and then labeled with
EasyTag™ EXPRESS 35S Protein Labeling Mix (NEG772007MC) for 1 h. To
determine the rates of protein synthesis, cell extracts were subjected to immuno-
precipitation with individual antibodies. Antibodies against MKK6 (9264, 1:250)
were purchased from Cell Signaling Technology. Antibody against Gapdh
(sc32233, 1:250) was purchased from Santa Cruz Biotechnology. The immuno-
precipitates were eluted and subjected to SDS-PAGE, and the gel was dried and
visualized with phosphoimaging.
Western blot analysis. For Villin-Cre; Tsc1f/f mice, villus tissues were scraped
from the small intestines. For Lgr5-CreERT; Tsc1f/f mice, crypts were isolated. In
these experiments, the mice were starved overnight and harvested in the following
morning. These samples were lysed in T-PER™ Tissue protein extraction reagent
purchased from Thermo Scientific (78510) containing 1 mM PMSF and 1 μg/ml
aprotonin, leupeptin, and pepstatin. Cells were lysed in TNEN buffer containing
1 mM PMSF and 1 μg/ml aprotonin, leupeptin, and pepstatin. The protein con-
centration was determined by a Bio-Rad assay. Proteins were resolved by SDS-
PAGE and transferred to polyvinylidenedifluoride membranes (Millipore). Anti-
bodies against MKK6 (9264, 1:1000), p-p38 (9211, 1:1000), p38 (9212, 1:1000), p-
Erk1/2 (9106, 1:1000), Erk1/2 (9102, 1:1000), cyclin E (4129, 1:1000), p53 (2524,
1:1000), p-S6 (1211, 1:1000), p-p70S6K (9234, 1:1000), p-4E-BP1 (2855, 1:1000),
4E-BP1 (9644, 1:1000), p-mTOR (5536, 1:1000), and mTOR (2983, 1:1000) were
purchased from Cell Signaling Technology. Antibodies against β-actin (sc81178,
1:1000), p16 (sc1207, 1:1000) and PCNA (sc-56, 1: 1000) were purchased from
Santa Cruz Biotechnology. The protein bands were quantitated using the software
provided by FluoChem M system (Protein Simple). Uncropped western blot images
can be found in Supplementary Fig. 11.
MKK6 knockdown. Silencer pre-designed siRNA targeting mouse MKK6 was
purchased from Gene Pharma (74366, 74367, 74368), which were transfected
intoTsc1+/+ and Tsc1−/− MEFs following the manufacturer’s protocol. Knock-
down efficiency was determined by western blot.
Quantitative PCR. The total RNA was extracted from cells, crypt, or villi tissues
with TRIzol reagent (Invitrogen) following the manufacturer’s protocol. Com-
plementary DNA was synthesized with 0.5 μg of the total RNA using Transcriptor
First Strand cDNA Synthesis Kit (Roche). The detection and quantification of target
mRNA were performed with real-time PCR, which was normalized to the levels of
β-actin. Real-time PCR was carried out using the Applied Biosystems 7500 system.
The following primers were used in this study: Mapk14 forward primer: 5′-
GGCACCTGCCATCAGTAGTT-3′, reverse primer: 5′-CCAGGGCTTCCAGAA
GACAG-3′; Mkk6 forward primer: 5′-GGCACCTGCCATCAGTAGTT-3′, reverse
primer: 5′-CCAGGGCTTCCAGAAGACAG-3′.
Villi and crypt quantitation. The numbers of villi per view (10 × 10 magnification)
were counted double blindly. The height of villi and crypts were measured from the
top to the bottom using NIKON-TiuNIS-Elements microscope. Each group has at
least three mice, and the results represent the average of five sections per mouse.
Statistical analysis. The data are expressed as the mean with the standard error of
the mean (±SEM) or as mean with standard deviation (±SD), if replicates are used.
The number of samples (n) is indicated in the figure legends. Unpaired two-tailed
Student’s t test was applied to determine the significance of the differences between
two groups and P-value < 0.05 was considered as statistically significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data for Figs. 1a–e, g, h, 2a–d, 3a–d, 4a–e, 5a–d, 6a–f, 7a–d and
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provided as a Source Data file. The remaining data are contained within the article,
supplementary information, or available from the authors upon request. A reporting
summary for this article is available as a Supplementary Information file.
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